New kidney treatment techniques achieved impressive results in some studies, with one method showing 71% kidney recovery ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...

Curious to know which obesity stories grabbed the attention of readers this year? Medscape Medical News develops a list of ...

A new method of reversing Alzheimer's shows promise in an animal study, as researchers at University Hospitals restore brain ...

USA: A large US-based phase III clinical trial has shown that proton radiotherapy offers a meaningful survival advantage and ...

The KEYNOTE-775 study confirms long-term benefits of Lenvatinib and Pembrolizumab for recurrent endometrial cancer, showing ...

A moderate shift to include more advanced practice providers in nursing homes can lead to measurable improvements in patient outcomes, a new study has found. Some 41% of nursing homes increased use of ...

For many women living with advanced breast cancer, everyday activities can become more difficult over time. Fatigue, pain, and loss of muscle strength are common problems caused by both the illness ...

Exercise can help women with advanced breast cancer better withstand both cancer treatments and the ravages of the disease, a new clinical trial shows. A nine-month program of supervised aerobic and ...

Twenty-year follow-up demonstrated continued imatinib efficacy in advanced GIST with doubled median overall survival. Imatinib (Gleevec) showed durable efficacy in advanced gastrointestinal stromal ...

Please provide your email address to receive an email when new articles are posted on . The PFS benefit from adding a vaccine to pembrolizumab narrowly missed the statistical significance threshold.